FOI release

FOI2021/00045: UKRI Grant to Sareum Ltd to Explore the Potential of SDC-1801, a Selective TYK2/JAK1 Inhibitor

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2021/00045

Published 22 June 2021

Request

Request Received: 5 February 2021

Please provide:

1) a copy of the UKRI grant funding application submitted by Sareum Limited, in respect of the exploration of the potential of the experimental drug SDC1801 in the treatment of Covid-19 related illness.

2) a copy of the grant award notification.

3) details of the timeline and anticipated milestones for the research project.

Response

Response Sent: 3 March 2021

Full details of this response are provided in the attached document.

Documents

• FOI_Response_Letter_FOI2021_00045_Redacted.pdf (167.0 KB)

This is UK Research and Innovation's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.